NCT04616404View on ClinicalTrials.gov

The Metabolic Effects of Cynara Supplementation in Overweight and Obese Class I Subjects With Newly Detected Impaired Fasting Glycaemia.

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Insulin SensitivityObesityOverweight
Interventions
DIETARY_SUPPLEMENT

500 mg of artichoke extract

Tablets containing 500 mg of artichoke extract (triple standardized to contain caffeoylquinic acids ≥ 5.0%; flavonoids ≥ 1.5%; cynaropicrin ≥ 1.0%, by HPLC)

OTHER

Placebo

Tablets with no active ingredient

Trial Locations (1)

27100

Azienda di Servizi alla Persona ''Istituto Santa Margherita'', Pavia

All Listed Sponsors
collaborator

Indena S.p.A

INDUSTRY

lead

Azienda di Servizi alla Persona di Pavia

OTHER

NCT04616404 - The Metabolic Effects of Cynara Supplementation in Overweight and Obese Class I Subjects With Newly Detected Impaired Fasting Glycaemia. | Biotech Hunter | Biotech Hunter